Skip to main content
OpenTrials
Completed

NCT Number: NCT03719846

Continuous Sample Collection Study

This study will provide urine cycles from both pregnant and not pregnant volunteers to maintain the SPD sample bank.

Study volunteers, seeking to conceive will be provided with Clearblue Ovulation product to help them pinpoint their most fertile time and aid conception. All volunteers will provide daily early morning urine samples throughout the study period and keep a study diary of menses and pregnancy test results for 1 menstrual cycle.

Urine samples will be received in the clinical laboratory and aliquoted into 2.25ml amounts at stored at -80˚C until required.

The study will also gather optional information from volunteers regarding a woman's general health and stress levels when trying to conceive. This will be used to study the relationship between general health, stress and conception.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Age range

18 year–40 year

Sex eligibility

Female

Study type

Observational

Primary location

SPD Development Company Ltd

Bedford, Bedfordshire, MK44 3UP, United Kingdom

About this study

This study will provide urine cycles from both pregnant and not pregnant volunteers to maintain the SPD sample bank.

Study volunteers, seeking to conceive will be recruited to the study after providing written informed consent. All volunteers will be provided with Clearblue Ovulation product to help them pinpoint their most fertile time and aid conception and be required to collect daily early morning urine samples throughout the study until pregnancy is conformed or their next menstrual period starts. Volunteers will be required to keep a daily diary of menses, sample collection and pregnancy test results. The study will last for 1 menstrual cycle.

Urine samples will be received in the clinical laboratory will be tested for the presence of hormones related to pregnancy and fertility, then aliquoted into 2.25ml amounts at stored in the SPD BioBank at -80˚C until required for product development or evaluation .

The study will also gather optional information from volunteers regarding a woman's general health and stress levels when trying to conceive. This will be used to study the relationship between general health, stress and conception.

Demographic data will be summarised. No statistical analysis will be conducted on the data.

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Females aged 18-40 years actively trying to conceive
  • At least 2 regular consecutive cycles since last pregnancy/miscarriage/or since stopping breastfeeding
  • Willing to disclose their pregnancy status and provide urine samples.
  • Willing to give informed consent and comply with the investigational procedures.

Exclusion criteria

  • Conditions that contraindicated pregnancy
  • Taking medication, or has known condition which means they should not get pregnant.
  • Currently pregnant or breastfeeding
  • Abnormal liver or kidney function
  • Taking antibiotics containing tetracycline.
  • Previously participated in this study

Treatment and study plan

Primary outcomes

  1. Collection of urine samples during conception cycle

    Time frame: 2 years

    Daily during samples collected throughout the cycle in which conception occurs

Sponsors and collaborators

Lead sponsor

SPD Development Company Limited

Industry

Registry information

Acronym: CSC

Important dates

Study start
2018
Primary completion
2020
Study completion
2021
First posted
Oct 25, 2018
Registry last updated
Nov 2, 2022

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.